Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma

NCT01964235 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was cancelled by Sponsor.

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: INC280
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals